Homepage
Medication Guide
Indication of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a small-molecule inhibitor targeting the MET kinase, developed by Novartis and granted accelerated approval by the U.S. FDA in 2020. As a precision therapy, it has demonstrate...
515
Saturday, October 11th, 2025, 17:13
How to Administer Cemiplimab
Cemiplimab is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not ca...
514
Saturday, October 11th, 2025, 16:25
Precautions for Cemiplimab Administration
Cemiplimab is a PD-1 inhibitor indicated for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not candidates for curative surgery or radia...
507
Saturday, October 11th, 2025, 16:03
What Are the Side Effects of Cemiplimab?
Cemiplimab is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not ca...
509
Saturday, October 11th, 2025, 15:22
How to Purchase Zongertinib
Zongertinib is a targeted therapeutic agent for non-small cell lung cancer (NSCLC) harboring activating mutations in the tyrosine kinase domain of HER2 (ERBB2). Due to its specificity and potential ef...
507
Saturday, October 11th, 2025, 15:03
Indication of Zongertinib
Zongertinib is a novel kinase inhibitor recently granted accelerated approval by the U.S. FDA. As a targeted therapy for specific patients with non-small cell lung cancer (NSCLC), its key information—...
509
Saturday, October 11th, 2025, 14:58
How to Use Zongertinib
Zongertinib is a novel kinase inhibitor indicated for the treatment of adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) harboring activating mutations in ...
508
Saturday, October 11th, 2025, 14:34
Precautions for Zongertinib Administration
Zongertinib is a kinase inhibitor that targets activating mutations in the tyrosine kinase domain of HER2 (ERBB2). It is indicated for the treatment of adult patients with unresectable or metastatic n...
510
Saturday, October 11th, 2025, 14:31
What Are the Side Effects of Zongertinib?
Zongertinib is a kinase inhibitor targeting activating mutations in the tyrosine kinase domain of HER2 (ERBB2). It is indicated for the treatment of unresectable or metastatic non-squamous non-small c...
510
Saturday, October 11th, 2025, 14:24
How to Purchase Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar)
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a combined antihypertensive drug manufactured by Merck & Co., Inc. It is mainly used for the treatment of hypertension and reducing t...
510
Saturday, October 11th, 2025, 14:21
108 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved